DrLullaby is a digital platform that provides evidence-based Cognitive Behavioral Therapy for Insomnia (CBT-I) through telehealth sessions and secure messaging, enabling personalized treatment plans tailored by licensed clinicians. The platform addresses the widespread issue of insomnia by offering a non-pharmaceutical approach that helps patients improve sleep onset, duration, and quality, with a reported 70% success rate.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Millions suffer from insomnia, which can diminish energy, mood, work and family life, and overall health. Access to Cognitive Behavioral Treatment for Insomnia (CBT-I), the recommended first-line treatment, is limited due to the scarcity of specially trained clinicians. Sleeping pills, often used as a quick fix, can lead to dependency and carry the risk of side effects.
Solution
DrLullaby provides access to clinicians trained in insomnia treatment through live video visits and secure messaging. The platform's technology facilitates clinical care and sleep analysis. By integrating with wearable technologies, DrLullaby enables patients to collaborate with experts who can analyze and enhance their sleep patterns. The platform helps patients fall asleep faster, return to sleep with ease, and taper off sleeping pills safely.
Target Audience
DrLullaby's primary customers are individuals suffering from insomnia and primary care physicians seeking effective sleep solutions for their patients.
Features
- Telehealth sessions with licensed clinicians trained in CBT-I
- Secure messaging for ongoing support and adjustments to sleep plans
- Digital platform for sleep data analysis and actionable feedback
- Integration with wearable technologies like Oura for personalized data insights
- Personalized guidance to reduce insomnia symptoms
- Support for medication tapering